Completed
Transgender women removing healthcare barriers to engagement in the HIV prevention and care cascades
Learn MoreOngoing
Preventing HIV by targeting the immune system instead of the virus
Learn MoreOngoing
Reporting
Improving vaginal health to decrease biological risk of HIV-1 infection in Canadian ACB women
Learn MoreReporting
Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (ECF/TAF) Switch followed by Sofosbuvir/Velpatasvir (SOF/VEL) Antiviral HCV Therapy in HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy — A Pilot Feasibility Study
Learn MoreStart-up
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses
Learn MoreOngoing
Indigenous, participatory evaluation and assessment of a culturally-grounded and arts-informed intervention for HIV-positive Aboriginal women
Learn MoreStart-up
Contextual Analysis of Urban and Rural Programs and Supports for First Nations and Métis People Living with HIV and other STBBIs
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
